首页> 外文期刊>International Urology and Nephrology >Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury
【24h】

Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury

机译:肾脏替代治疗期间严重的急性低磷血症严重影响重症急性肾损伤患者的预后

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose Hypophosphatemia during renal replacement therapy (RRT) is common in critically ill patients with acute kidney injury (AKI). The clinical consequences of RRT-induced phosphate depletion are not well defined in this patient population, and there is no evidence that intravenous sodium phosphate supplementation (PS) prevents the clinical sequelae of acute hypophosphatemia. The purpose of this retrospective analysis of the Acute Renal Support Registry of the University of Munich was to examine the association between severe hypophosphatemia and severity of and recovery from AKI. Methods 289 ICU patients with AKI on intermittent hemodialysis (IHD) were included in the study. One hundred and forty-nine patients received PS during IHD. Outcomes were short-term (at discharge) and long-term (at 1 year) recovery of renal function and mortality. Results The two patient groups did not differ in demographics, clinical features, renal characteristics, and frequency of hypophosphatemia at initiation of IHD. Without PS, the frequency of hypophosphatemia increased from 20 to 35%. Severe hypophosphatemia was found in 50% of these patients. By comparison, PS was not associated with an increased frequency of hypophosphatemia. Compared with patients with acute phosphate depletion, patients receiving PS developed less oliguria during IHD, had shorter duration of AKI, higher incidence of complete renal recovery at discharge, and a lower risk of de novo chronic kidney disease. Hypophosphatemia was associated with higher all-cause in-hospital mortality and higher risk of long-term mortality. Conclusions This multicenter study indicates for the first time that hypophosphatemia during IHD adversely affects short- and long-term outcome of critically-ill patients with AKI. The clinical consequences of the acute hypophosphatemic syndrome may be prevented by PS. ? Springer Science+Business Media Dordrecht 2013.
机译:目的肾替代疗法(RRT)期间的低磷酸盐血症在重症急性肾损伤(AKI)患者中很常见。在该患者人群中,RRT引起的磷酸盐耗竭的临床后果尚不明确,也没有证据表明静脉内补充磷酸钠(PS)可以预防急性低磷血症的临床后遗症。慕尼黑大学急性肾支持注册中心的这项回顾性分析的目的是检查严重的低磷血症与AKI的严重程度和康复之间的关系。方法将289例ICU间歇性血液透析(IHD)的AKI患者纳入研究。 IHD期间有149例患者接受了PS。结果是肾功能和死亡率的短期(出院)和长期(1年)恢复。结果两组患者在IHD开始时的人口统计学,临床特征,肾脏特征和低磷血症发生频率无差异。没有PS,低磷血症的发生率从20%增至35%。在这些患者中有50%发现严重的低磷血症。相比之下,PS与低磷血症发生频率增加无关。与急性磷酸盐耗竭的患者相比,接受PS的患者在IHD期间少尿少,AKI持续时间较短,出院时完全肾脏恢复的发生率较高,并且从新发生慢性肾脏病的风险较低。低磷血症与更高的全因住院死亡率和更高的长期死亡率风险相关。结论这项多中心研究首次表明,IHD期间的低磷酸盐血症会对重症AKI患者的短期和长期结局产生不利影响。 PS可预防急性低磷酸盐血症综合征的临床后果。 ? Springer Science + Business Media Dordrecht 2013。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号